Home > Insider Trading > Filing (0000890465-13-000033)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1474064	Ed Stratemeier	550 Hills Drive Bedminster NJ 07921	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-16	14,555	$3.60	56,894	No	4	M	Direct
Common Stock	Disposition	2013-12-16	14,555	$25.00	42,339	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2013-12-16	14,555	$0.00	14,555	$3.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
85,445		2019-10-19	No	4	M	Direct

Footnotes

The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 13, 2013.
Includes 960 shares of stock obtained through the Issuer's Employee Stock Purchase Program on September 30, 2013 and 1,028 shares of stock obtained through the Issuer's Employee Stock Purchase Program on March 31, 2013.
On October 19, 2009, the Reporting Person received a grant of 100,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 100,000 stock options have vested.